Company Filing History:
Years Active: 2014
Title: The Innovations of Patrick Dufner
Introduction
Patrick Dufner is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on addressing disorders associated with interleukin 17, a key player in inflammatory diseases.
Latest Patents
Dufner holds a patent titled "Antibodies to IL-17A and uses thereof." This patent involves binding members, especially antibody molecules, for interleukin 17 (IL-17). The binding members are particularly useful for the treatment of disorders such as rheumatoid arthritis, showcasing Dufner's commitment to advancing medical science.
Career Highlights
Patrick Dufner is associated with Medimmune Limited, a prominent company in the biopharmaceutical sector. His role at Medimmune allows him to collaborate with other experts in the field and contribute to innovative solutions for complex health issues.
Collaborations
Dufner has worked alongside notable colleagues, including Duncan James Cochrane and Caroline S. Russell. These collaborations enhance the research and development efforts within the company, fostering an environment of innovation.
Conclusion
Patrick Dufner's contributions to the field of biotechnology, particularly through his patent on IL-17A antibodies, highlight his role as a key innovator in medical research. His work continues to pave the way for new treatments for inflammatory disorders.